In the previous trading session, Indian equity markets exhibited measured movements as investors remained attentive to global cues and domestic corporate announcements.
Market participants are closely tracking stock-specific developments such as management changes, project wins, regulatory approvals and acquisitions, which are likely to influence trading sentiment in the near term.
Swiggy witnessed key board-level changes, with Co-founder Lakshmi Nandan Reddy Obul stepping down as Whole-Time Director – Head of Innovation. Additionally, nominee director Roger Clark Rabalais resigned. The company has appointed new directors, signalling a strategic leadership transition.
Enviro Infra Engineers secured two projects worth ₹972.2 crore from the Swachh Maharashtra Mission Directorate, strengthening its order book and reinforcing its position in the environmental infrastructure segment.
Advait Energy has emerged as the lowest bidder (L1) for a turnkey contract under the Vanbandhu Kalyan Yojana-2 scheme, highlighting its growing presence in energy transition and infrastructure execution.
Larsen & Toubro’s subsidiary, L&T Realty Properties, has acquired a 100% stake in International Green Scapes. The acquisition is expected to enhance its real estate portfolio and support future development opportunities.
Read More: TCS Declared ₹31 Final Dividend: Check Dividend History, Record Date and More!
AstraZeneca Pharma India received regulatory approval to import and market Acalabrutinib tablets (100 mg) in India. The drug is indicated for treating certain types of blood cancers, expanding the company’s oncology portfolio.
The US FDA completed an inspection of Torrent Pharma’s oncology manufacturing facility with zero observations, indicating strong compliance standards and boosting investor confidence.
Laxmi Organic Industries announced the resignation of its Chief Financial Officer, Mahadeo Karnik. Harshvardhan Goenka has been appointed as Interim CFO, ensuring continuity in financial leadership.
Praveer Kumar Srivastava has been appointed as Managing Director for a five-year term in Mahanagar Gas, while the current MD, Ashu Shinghal, will step down at the end of his tenure.
Lupin launched Dapagliflozin tablets in the United States following US FDA approval, marking a significant step in expanding its diabetes treatment portfolio in international markets.
Vakrangee entered into a strategic partnership with IndiaFirst Life Insurance to offer life insurance products, aiming to diversify its service offerings.
Corporate actions including leadership changes, regulatory approvals, acquisitions and order inflows are expected to drive stock-specific movements in today’s session.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks. Read all related documents carefully before investing.
Published on: Apr 13, 2026, 8:04 AM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
EN